Summary & Key Points
"Dr. Patrick Coffie, PAC-CI Scientific Director, presented at AFRAVIH 2026 in Lausanne the epidemiological challenges of HIV-hepatitis B co-infection, with a focus on African perspectives."
Continuing our series on the participation of the PAC-CI/PRISME-CI Program in AFRAVIH 2026, held in Lausanne, Switzerland, we highlight today the contribution of Prof. Ahoutatchi Patrick Coffie, Scientific Director of the PAC-CI Program.
On Tuesday, May 5, 2026, from 5:30 PM to 6:45 PM, Prof. Coffie took part in the symposium organized by Viiv Healthcare on the theme: “Toward the elimination of viral suppression in co-infection: perspectives on HIV and hepatitis B.”
On this occasion, he delivered an oral presentation titled: “HIV–HBV Co-infection: Global Epidemiology and African Perspective.”
This presentation provided scientific insight into the challenges of HIV–hepatitis B co-infection, with a particular focus on African realities.
Through this participation, the PAC-CI Program continues to share its scientific expertise in major international forums dedicated to HIV and chronic viral infections. See less
Christian KOUADIO
Clinical Research Associate and Communications Manager at PAC-CI
Contact the author
